Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Spebrutinib besylate (AVL-292 benzenesulfonate; CC-292 besylate) is a Btk kinase activity inhibitor (IC50<0.5 nM, Kinact/Ki=7.69×104 M-1s-1s).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Spebrutinib besylate (AVL-292 benzenesulfonate; CC-292 besylate) is a Btk kinase activity inhibitor (IC50<0.5 nM, Kinact/Ki=7.69×104 M-1s-1s). |
ターゲット&IC50 | BTK:<0.5 nM |
別名 | CC-292 (besylate), AVL-292 (benzenesulfonate) |
分子量 | 581.62 |
分子式 | C28H28FN5O6S |
CAS No. | 1360053-81-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Spebrutinib besylate 1360053-81-1 Angiogenesis Tyrosine Kinase/Adaptors BTK benzenesulfonate AVL 292 AVL292 CC 292 CC292 CC-292 (besylate) besylate CC-292 AVL-292 AVL-292 (benzenesulfonate) Inhibitor inhibitor inhibit